Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Fulcrum Therapeutics (FULC) Return on Sales: 2020-2024

Historic Return on Sales for Fulcrum Therapeutics (FULC) over the last 3 years, with Jun 2024 value amounting to -0.25%.

  • Fulcrum Therapeutics' Return on Sales rose 3210.00% to -0.25% in Q2 2024 from the same period last year, while for Jun 2024 it was -0.25%, marking a year-over-year increase of 3210.00%. This contributed to the annual value of -0.12% for FY2024, which is 3458.00% up from last year.
  • Per Fulcrum Therapeutics' latest filing, its Return on Sales stood at -0.25% for Q2 2024, which was up 99.29% from -34.70% recorded in Q4 2023.
  • Fulcrum Therapeutics' 5-year Return on Sales high stood at -0.25% for Q2 2024, and its period low was -37.69% during Q3 2023.
  • In the last 3 years, Fulcrum Therapeutics' Return on Sales had a median value of -17.32% in 2022 and averaged -19.08%.
  • In the last 5 years, Fulcrum Therapeutics' Return on Sales tumbled by 2,768bps in 2023 and then spiked by 3,210bps in 2024.
  • Over the past 5 years, Fulcrum Therapeutics' Return on Sales (Quarterly) stood at -8.03% in 2020, then spiked by 381bps to -4.22% in 2021, then crashed by 1,311bps to -17.32% in 2022, then slumped by 1,738bps to -34.70% in 2023, then soared by 3,210bps to -0.25% in 2024.
  • Its last three reported values are -0.25% in Q2 2024, -34.70% for Q4 2023, and -37.69% during Q3 2023.